Source: Fred Hutch Linkedin
On October 19th 2026, Dr. Swisher was elected to the National Academy of Medicine, one of the highest honors in health and medicine. She was recognized
“[f]or defining the genetic landscape of hereditary ovarian cancer and changing how we assess risk and prevent these cancers. She led clinical development of PARP inhibitors, discovering mechanisms of sensitivity and resistance that have fundamentally changed the standard of care and extended survival for countless women with ovarian cancer.”
You can read more about Dr. Swisher’s election in Fred Hutch’s Linkedin post as well as NAM’s news release.
Congratulations Liz!
